Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 2/2015

01.02.2015 | Head and Neck

Clinicopathological characteristics of carcinoma from unknown primary in cervical lymph nodes

verfasst von: Daniel Weiss, Mario Koopmann, Markus Stenner, Eleftherios Savvas, Claudia Rudack

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Carcinoma in cervical lymph nodes of unknown origin represents a rare clinical entity where optimal diagnostic and therapeutic management is still a widely debated issue. Molecular classification of these metastases is thus of utmost importance. We analyzed the expression of eight basic molecular markers in 26 metastases from unknown primaries, 31 metastases from overt primaries and their associated primaries. Medical records of the respective patients were reviewed for main clinicopathological parameters. The expression rates showed no significant differences between the two tumor entities, neither in absolute terms nor in comparison among the parameters. Surprisingly, patients with metastases from unknown primary demonstrated improved progression-free survival (p = 0.046) despite advanced age (p = 0.029), advanced nodal stage (p = 0.006) and higher incidence of extracapsular spread (p = 0.045) compared to patients with metastases from overt primaries. Presence of extracapsular spread was associated with increased expression of epidermal growth factor receptor in metastases from overt primaries (p = 0.035) and reduced expression of matrix metalloproteinase-2 in metastases from unknown primary (p = 0.031). We thus conclude that cervical metastases from unknown and overt primaries show similarities in their molecular profile, but fundamental differences in clinical parameter.
Literatur
1.
2.
Zurück zum Zitat Cianchetti M, Mancuso AA, Amdur RJ et al (2009) Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 119:2348–2354PubMedCrossRef Cianchetti M, Mancuso AA, Amdur RJ et al (2009) Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 119:2348–2354PubMedCrossRef
3.
Zurück zum Zitat Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB (2000) Cervical lymph node metastases from unknown primary tumours. results from a national survey by the Danish society for head and neck oncology. Radiother Oncol 55:121–129PubMedCrossRef Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB (2000) Cervical lymph node metastases from unknown primary tumours. results from a national survey by the Danish society for head and neck oncology. Radiother Oncol 55:121–129PubMedCrossRef
4.
Zurück zum Zitat Haas I, Hoffmann TK, Engers R, Ganzer U (2002) Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 259:325–333PubMedCrossRef Haas I, Hoffmann TK, Engers R, Ganzer U (2002) Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 259:325–333PubMedCrossRef
5.
Zurück zum Zitat Jereczek-Fossa BA, Jassem J, Orecchia R (2004) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 30:153–164PubMedCrossRef Jereczek-Fossa BA, Jassem J, Orecchia R (2004) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 30:153–164PubMedCrossRef
6.
Zurück zum Zitat Pavlidis N, Pentheroudakis G, Plataniotis G (2009) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clin Transl Oncol 11:340–348PubMedCrossRef Pavlidis N, Pentheroudakis G, Plataniotis G (2009) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clin Transl Oncol 11:340–348PubMedCrossRef
7.
Zurück zum Zitat Yoo J, Henderson S, Walker-Dilks C (2013) Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clin Oncol (R Coll Radiol) 25:e33–e66CrossRef Yoo J, Henderson S, Walker-Dilks C (2013) Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clin Oncol (R Coll Radiol) 25:e33–e66CrossRef
8.
Zurück zum Zitat Wong WL, Sonoda LI, Gharpurhy A et al (2012) 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers—an audit and review of published studies. Clin Oncol (R Coll Radiol) 24:190–195CrossRef Wong WL, Sonoda LI, Gharpurhy A et al (2012) 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers—an audit and review of published studies. Clin Oncol (R Coll Radiol) 24:190–195CrossRef
9.
Zurück zum Zitat Rudmik L, Lau HY, Matthews TW et al (2011) Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial. Head Neck 33:935–940PubMedCrossRef Rudmik L, Lau HY, Matthews TW et al (2011) Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial. Head Neck 33:935–940PubMedCrossRef
10.
Zurück zum Zitat Kwee TC, Kwee RM (2009) Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 19:731–744PubMedCentralPubMedCrossRef Kwee TC, Kwee RM (2009) Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 19:731–744PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Pattani KM, Goodier M, Lilien D, Kupferman T, Caldito G, Nathan CO (2011) Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan. Ear Nose Throat J 90:E16–E20PubMed Pattani KM, Goodier M, Lilien D, Kupferman T, Caldito G, Nathan CO (2011) Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan. Ear Nose Throat J 90:E16–E20PubMed
12.
Zurück zum Zitat Ryu IS, Choi SH, Kim do H et al (2013) Detection of the primary lesion in patients with cervical metastases from unknown primary tumors with narrow band imaging endoscopy: preliminary report. Head Neck 35:10–14PubMedCrossRef Ryu IS, Choi SH, Kim do H et al (2013) Detection of the primary lesion in patients with cervical metastases from unknown primary tumors with narrow band imaging endoscopy: preliminary report. Head Neck 35:10–14PubMedCrossRef
13.
Zurück zum Zitat Robbins KT, Shaha AR, Medina JE et al (2008) Committee for neck dissection classification, American head and neck society. consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRef Robbins KT, Shaha AR, Medina JE et al (2008) Committee for neck dissection classification, American head and neck society. consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRef
14.
Zurück zum Zitat Cardesa AN, Gale N, Nadal A, Zidar N (2005) Tumors of the Oral Cavity and Oropharynx. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization classification of tumours, pathology and genetics of head and neck tumors, vol 9. IARC Press, Lyon, pp 118–181 Cardesa AN, Gale N, Nadal A, Zidar N (2005) Tumors of the Oral Cavity and Oropharynx. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization classification of tumours, pathology and genetics of head and neck tumors, vol 9. IARC Press, Lyon, pp 118–181
15.
Zurück zum Zitat Weiss D, Stockmann C, Schrödter K, Rudack C (2013) Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma. Cell Oncol 36:213–224CrossRef Weiss D, Stockmann C, Schrödter K, Rudack C (2013) Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma. Cell Oncol 36:213–224CrossRef
16.
Zurück zum Zitat Califano J, Westra WH, Koch W et al (1999) Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 91:599–604PubMedCrossRef Califano J, Westra WH, Koch W et al (1999) Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 91:599–604PubMedCrossRef
18.
Zurück zum Zitat Park JM, Jung CK, Choi YJ et al (2010) The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma. Hum Pathol 41:431–437PubMedCrossRef Park JM, Jung CK, Choi YJ et al (2010) The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma. Hum Pathol 41:431–437PubMedCrossRef
19.
Zurück zum Zitat Weiss D, Koopmann M, Rudack C (2011) Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck 33:856–862PubMedCrossRef Weiss D, Koopmann M, Rudack C (2011) Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck 33:856–862PubMedCrossRef
20.
Zurück zum Zitat Leemans CR, Braakhuis BJM, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22PubMedCrossRef Leemans CR, Braakhuis BJM, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22PubMedCrossRef
21.
Zurück zum Zitat Pentheroudakis G, Briasoulis E, Pavlidis N (2007) Cancer of unknown primary site: missing primary or missing biology? Oncologist 12:418–425PubMedCrossRef Pentheroudakis G, Briasoulis E, Pavlidis N (2007) Cancer of unknown primary site: missing primary or missing biology? Oncologist 12:418–425PubMedCrossRef
22.
Zurück zum Zitat Do NY, Lim SC, Im TS (2004) Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck. Oncol Rep 12:229–237PubMed Do NY, Lim SC, Im TS (2004) Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck. Oncol Rep 12:229–237PubMed
23.
Zurück zum Zitat Kim JM, Kim HJ, Koo BS, Rha KS, Yoon YH (2013) Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 270:1137–1142PubMedCrossRef Kim JM, Kim HJ, Koo BS, Rha KS, Yoon YH (2013) Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 270:1137–1142PubMedCrossRef
24.
Zurück zum Zitat Michikawa C, Uzawa N, Sato H, Ohyama Y, Okada N, Amagasa T (2011) Epidermal growth factor receptor gene copy number aberration at the primary tumour is significantly associated with extracapsular spread in oral cancer. Br J Cancer 104:850–855PubMedCentralPubMedCrossRef Michikawa C, Uzawa N, Sato H, Ohyama Y, Okada N, Amagasa T (2011) Epidermal growth factor receptor gene copy number aberration at the primary tumour is significantly associated with extracapsular spread in oral cancer. Br J Cancer 104:850–855PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Beldì D, Jereczek-Fossa BA, D’Onofrio A et al (2007) Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 69:1051–1058PubMedCrossRef Beldì D, Jereczek-Fossa BA, D’Onofrio A et al (2007) Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 69:1051–1058PubMedCrossRef
26.
Zurück zum Zitat Perkins SM, Spencer CR, Chernock RD et al (2012) Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg 138:656–661PubMedCrossRef Perkins SM, Spencer CR, Chernock RD et al (2012) Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg 138:656–661PubMedCrossRef
27.
Zurück zum Zitat Balaker AE, Abemayor E, Elashoff D, St John MA (2012) Cancer of unknown primary: does treatment modality make a difference? Laryngoscope 122:1279–1282PubMedCrossRef Balaker AE, Abemayor E, Elashoff D, St John MA (2012) Cancer of unknown primary: does treatment modality make a difference? Laryngoscope 122:1279–1282PubMedCrossRef
28.
Zurück zum Zitat McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM (1998) Occult tonsillar carcinoma in the unknown primary. Laryngoscope 108:1605–1610PubMedCrossRef McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM (1998) Occult tonsillar carcinoma in the unknown primary. Laryngoscope 108:1605–1610PubMedCrossRef
29.
Zurück zum Zitat Compton AM, Moore-Medlin T, Herman-Ferdinandez L et al (2011) Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 145:51–57PubMedCrossRef Compton AM, Moore-Medlin T, Herman-Ferdinandez L et al (2011) Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 145:51–57PubMedCrossRef
30.
Metadaten
Titel
Clinicopathological characteristics of carcinoma from unknown primary in cervical lymph nodes
verfasst von
Daniel Weiss
Mario Koopmann
Markus Stenner
Eleftherios Savvas
Claudia Rudack
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2015
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-2980-z

Weitere Artikel der Ausgabe 2/2015

European Archives of Oto-Rhino-Laryngology 2/2015 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.